iridium radioisotopes has been researched along with Telangiectasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graves, TA; Hepel, JT; Leonard, KL; Mastras, D; Pittier, A; Sha, S; Wazer, DE; Wiggins, DL | 1 |
| Beriwal, S; Heron, DE; Johnson, R; Kalash, R; Kim, H; Vargo, JA; Verma, V | 1 |
1 trial(s) available for iridium radioisotopes and Telangiectasis
| Article | Year |
|---|---|
Phase 2 Trial of Accelerated Partial Breast Irradiation (APBI) Using Noninvasive Image Guided Breast Brachytherapy (NIBB).
Topics: Aged; Aged, 80 and over; Brachytherapy; Breast; Breast Diseases; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Dose Fractionation, Radiation; Female; Humans; Immobilization; Iridium Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radiotherapy, Image-Guided; Telangiectasis; Treatment Outcome | 2020 |
1 other study(ies) available for iridium radioisotopes and Telangiectasis
| Article | Year |
|---|---|
Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity.
Topics: Aged; Aged, 80 and over; Brachytherapy; Breast Neoplasms; Female; Follow-Up Studies; Humans; Incidence; Iridium Radioisotopes; Mastectomy, Segmental; Middle Aged; Neoplasms, Second Primary; Patient Selection; Radiotherapy Dosage; Retrospective Studies; Skin; Survival Rate; Telangiectasis; Treatment Outcome | 2014 |